Overview
Hello Heart provides a digital therapeutics program for cardiovascular health that includes a free blood pressure monitor and a mobile app to track heart metrics and manage conditions, offered through employers and health plans as a covered benefit (B2B2C). The product connects a blood pressure monitor to the app, allowing users to track blood pressure, cholesterol, and medications, with personalized health insights and coaching informed by behavioral science. It stands out by combining medical hardware with targeted cardiovascular care and coaching, delivered through a scalable employer-sponsored model focused on prevention and reducing costs for employers. The goal is to improve population heart health while lowering healthcare expenses by preventing and better managing chronic cardiovascular conditions through technology, monitoring hardware, and behavioral coaching.
Work here?Claim your company
Simplify's Take
What believers are saying
- May 2026 Circulation study found higher enrollment among lower-income members and fewer ED visits.
- August 2026 heart-failure study reported $7,001 lower medical spend and fewer hospitalizations.
- October 2025 Nia launch deepens engagement, extending coach-like support between clinician visits.
What critics are saying
- Employer ROI proof still depends on self-reported savings and usage, weakening renewal leverage.
- Category incumbents like CVS, Aetna, and digital point-solution platforms can bundle away differentiation.
- If ACC validation fails or outcomes disappoint, health-plan adoption and valuations compress fast.
What makes Hello Heart unique
- Hello Heart combines connected monitors, app coaching, and medication support in one workflow.
- ACC collaboration in March 2026 validates clinical credibility and EMR integration ambitions.
- Navitus distribution in September 2025 expands access through PBM contracting and billing.
Help us improve and share your feedback! Did you find this helpful?